10 stocks Wall Street expects to roar back after dropping at least 20% in 2026

Analysts expect these stocks to soar at least 46% over the next 12 months.

Market Watch • 14 hours ago

Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects

Explore IQVIA's (IQV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks Investment Research • Feb 18, 2026

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ron Bruehlman, chief financial officer, and Mike Fedock, senior vice president, financial planning & analysis and incoming CFO, will speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026,.

Business Wire • Feb 18, 2026

Is the Options Market Predicting a Spike in IQVIA Stock?

Investors need to pay close attention to IQVIA stock based on the movements in the options market lately.

Zacks Investment Research • Feb 13, 2026

Oakmark Global All Cap Strategy Q4 2025 Performance Review

Oakmark Global All Cap Strategy portfolio's return was 4.99% (net) for the reporting period vs. MSCI World Index that returned 3.12% for the same period. Contributors in the quarter were DSV, IQVIA Holdings and Samsung Electronics Pfd. Detractors in the quarter were Alibaba Group, CNH Industrial and Dassault Systemes.

Seeking Alpha • Feb 12, 2026

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical Research Institute (DCRI), one of the world's largest academic clinical research organizations with extensive experience designing and operationally executing large, complex multi-center clinical trials, are pleased to announce their new collaboration to enha.

Business Wire • Feb 10, 2026

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 6, 2026

IQVIA forecasts weak annual profit on higher interest expenses

Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong fourth-quarter results underscored improving demand from pharmaceutical clients.

Reuters • Feb 5, 2026

IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y

IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.

Zacks Investment Research • Feb 5, 2026

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 5, 2026